Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Topoisomerase I and RecQL1 function in Epstein-Barr virus lytic reactivation.

Wang P, Rennekamp AJ, Yuan Y, Lieberman PM.

J Virol. 2009 Aug;83(16):8090-8. doi: 10.1128/JVI.02379-08. Epub 2009 Jun 3.

2.

The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins.

Gao Z, Krithivas A, Finan JE, Semmes OJ, Zhou S, Wang Y, Hayward SD.

J Virol. 1998 Nov;72(11):8559-67.

3.

Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication.

Wiedmer A, Wang P, Zhou J, Rennekamp AJ, Tiranti V, Zeviani M, Lieberman PM.

J Virol. 2008 May;82(9):4647-55. doi: 10.1128/JVI.02198-07. Epub 2008 Feb 27.

4.

The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.

Su MT, Wang YT, Chen YJ, Lin SF, Tsai CH, Chen MR.

J Virol. 2017 Apr 13;91(9). pii: e02114-16. doi: 10.1128/JVI.02114-16. Print 2017 May 1.

5.

A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication.

Wang P, Day L, Dheekollu J, Lieberman PM.

J Virol. 2005 Nov;79(21):13298-309.

7.

Evidence for DNA hairpin recognition by Zta at the Epstein-Barr virus origin of lytic replication.

Rennekamp AJ, Wang P, Lieberman PM.

J Virol. 2010 Jul;84(14):7073-82. doi: 10.1128/JVI.02666-09. Epub 2010 May 5.

8.

Potent antiviral activity of topoisomerase I and II inhibitors against Kaposi's sarcoma-associated herpesvirus.

González-Molleda L, Wang Y, Yuan Y.

Antimicrob Agents Chemother. 2012 Feb;56(2):893-902. doi: 10.1128/AAC.05274-11. Epub 2011 Nov 21.

9.

PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.

Lupey-Green LN, Moquin SA, Martin KA, McDevitt SM, Hulse M, Caruso LB, Pomerantz RT, Miranda JL, Tempera I.

Virology. 2017 Jul;507:220-230. doi: 10.1016/j.virol.2017.04.006. Epub 2017 Apr 26.

11.

Contribution of C/EBP proteins to Epstein-Barr virus lytic gene expression and replication in epithelial cells.

Huang J, Liao G, Chen H, Wu FY, Hutt-Fletcher L, Hayward GS, Hayward SD.

J Virol. 2006 Feb;80(3):1098-109.

12.
13.

Inhibition of the Epstein-Barr virus lytic cycle by Zta-targeted RNA interference.

Chang Y, Chang SS, Lee HH, Doong SL, Takada K, Tsai CH.

J Gen Virol. 2004 Jun;85(Pt 6):1371-9.

PMID:
15166418
15.

Repression of CIITA by the Epstein-Barr virus transcription factor Zta is independent of its dimerization and DNA binding.

Balan N, Osborn K, Sinclair AJ.

J Gen Virol. 2016 Mar;97(3):725-32. doi: 10.1099/jgv.0.000369. Epub 2015 Dec 11.

16.

DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.

Wang'ondu R, Teal S, Park R, Heston L, Delecluse H, Miller G.

PLoS One. 2015 May 7;10(5):e0126088. doi: 10.1371/journal.pone.0126088. eCollection 2015.

17.

Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivation.

Deng Z, Chen CJ, Zerby D, Delecluse HJ, Lieberman PM.

J Virol. 2001 Nov;75(21):10334-47.

18.
19.

Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.

Zhang Q, Hong Y, Dorsky D, Holley-Guthrie E, Zalani S, Elshiekh NA, Kiehl A, Le T, Kenney S.

J Virol. 1996 Aug;70(8):5131-42.

20.

Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation.

Tsai PF, Lin SJ, Weng PL, Tsai SC, Lin JH, Chou YC, Tsai CH.

J Virol. 2011 Mar;85(5):2373-85. doi: 10.1128/JVI.01602-10. Epub 2010 Dec 15.

Supplemental Content

Support Center